| 201/318 | US=86 / Biol/Mol Tan TT, White E. Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 81-104. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. SEGMENTACAO TERAPEUTICO; VIAS DE MORTE EM CANCER; MECANISMOS; MORTE CELULAR; CELULAS CANCERIGENAS; APOPTOSE; QUIMIOTERAPIA; TERAPIA ALVO; FAMILIA BCL-2; RECEPTORES DE MORTE; INIBIDORES DO SINAL DE TRANSDUCAO |
| 202/318 | US=86 / Biol/Mol Hersey P, Zhang XD, Mhaidat N. Overcoming resistance to apoptosis in cancer therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 105-26. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. TERAPIA DO CANCER; RESISTENCIA A APOPTOSE; ONCOGENE; MELANOMA; FAMILIA BCL-2 |
| 203/318 | US=86 / Biol/Mol Humphreys RC, Halpern W. Trail receptors: targets for cancer therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 127-58. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. TERAPIA DO CANCER; RECEPTORES TRAIL; APOPTOSE; ANTICORPOS MONOCLONAIS |
| 204/318 | US=86 / Biol/Mol Moore VDG, Letai A. Rational design of therapeutics targeting the BCL-2 family: are some cancer cells primed for death but waiting for a final push?. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 159-75. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. MORTE CELULAR; APOPTOSE; FAMILIA BCL-2; BH3; TERAPEUTICA; PEPTIDEOS |
| 205/318 | US=86 / Biol/Mol Kuribayashi K, El-Deiry W. Regulation of programmed cell death by the P53 pathway. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 201-21. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. REGULACAO DA MORTE CELULAR PROGRAMADA; VIA P53; APOPTOSE; TRANSCRICAO; RECEPTORES TRAIL; MORTE CELULAR DEPENDENTES DE P53 |
| 206/318 | US=86 / Biol/Mol Fan Y, Dutta J, Gupta N, Fan G, Gélinas C. Regulation of programmed cell death by NF-kB and its role in tumorigenesis and therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 223-50. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. REGULACAO DA MORTE CELULAR; NF-KB; TUMORIGENESE; TERAPIA; APOPTOSE; NECROSE; FATOR DE TRANSCRICAO; CANCER |
| 207/318 | US=86 / Biol/Mol Chauhan D, Hideshima T, Anderson KC. Targeting proteasomes as therapy in multiple myeloma. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 251-60. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. PROTEOSOMAS; SEGMENTACAO; TERAPIA; MIELOMA MULTIPLO; APOPTOSE; RESISTENCIA A DROGA; BORTEZOMIBE |
| 208/318 | US=86 / Biol/Mol Shankar S, Srivastava RK. Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HAC inhibitor-induced apoptosis. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 261-98. (Advances in Experimental Medicina and Biology volume 615) ISBN 978-1-4020-6553-8. INIBIDORES DE HISTONA DESACETILASE; CANCER; APOPTOSE INDUZIDA POR INIBIDORES; INIBIDORES HDAC; HAT; SAHA; MS-275; TSA; TRAIL; CASPASE |
| 209/318 | US=86 / Biol/Mol Jagani Z, Khosravi-Far R. Cancer stem cells and impaired apoptosis. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 331-44. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. CELULAS-TRONCO; CANCER; APOPTOSE; TERAPIA; LEUCEMIA; WNT; BMI1 |
| 210/318 | US=90 / Biol/Mol Domin J. EGFR signaling networks: phosphoinositide 3-kanase enzymes as downstrem targets of the EGF receptor. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 97-117. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. AKT; FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR; QUINASE; FOSFATIDILINOSITOL; TRANSDUCAO DE SINAL; CELULA; CANCER; MITOGENESE; APOPTOSE; ENDOCITOSE |
| 211/318 | US=98 / Biol/Mol Kerr JFR. A personal history of the development of the apoptosis concept. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 1-11. ISBN 978-084939192-7. HISTORIA CONCEITO DE APOPTOSE; DESENVOLVIMENTO DO CONCEITO DE APOPTOSE; ENCOLHIMENTO; NECROSE; TUMORES MALIGNOS |
| 212/318 | US=98 / Biol/Mol Wilson GD. What do the clinical data tell us about the role of apoptosis in sensitivity to cancer therapy?. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 13-39. ISBN 978-084939192-7. |
| 213/318 | US=98 / Biol/Mol Brown M. Response of solid tumors to cancer therapy: how relevant is apoptosis. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 41-53. ISBN 978-084939192-7. |
| 214/318 | US=98 / Biol/Mol Bredesen DE. Toward a mechanistic taxonomy for programmed cell death pathways. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 73-91. ISBN 978-084939192-7. |
| 215/318 | US=98 / Biol/Mol Egger L. Caspase-independent apoptotic cell death. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 93-108. ISBN 978-084939192-7. CASPASE-INDEPENDENTE DE MORTE CELULAR POR APOPTOSE; INIBICAO DA CASPASE; SINTETICOS INIBIDORES DE CASPASES; CASPASE-MORTE CELULAR INDEPENDENTE |
| 216/318 | US=98 / Biol/Mol Fan Y, Ullman E, Zong WX. The cellular decision between apoptosis and autophagy. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 127-41. ISBN 978-084939192-7. |
| 217/318 | US=1 / Química Harnett MM, Goodridge HS. Crescimento celular, diferenciação e câncer. In: Baynes JW, Dominiczak MH. Bioquímica médica. 2ª ed. Rio de Janeiro: Elsevier, 2007. p. 601-17. ISBN 85-3522298-2. CICLO CELULAR; FATORES DE CRESCIMENTO CELULAR; RECEPTOR PDGF; RECEPTOR DE CITOCINA; REGULACAO DO CICLO CELULAR; APOPTOSE; CASPASE; CANCER; ONCOGENE; GENES SUPRESSORES DE TUMOR |
| 218/318 | US=7 / Transplante Colton CK, Papas KK, Pisania A, Rappel MJ, Powers DE, O'Neil JJ, Omer A, Weir G, Bonner-Weir S. Cell therapy for peripheral diseases and reconstructive applications: characterization of islet preparations. In: Halberstadt C, Emerich D, editors. Cellular transplantation: from laboratory to clinic. Amsterdam: Elsevier, 2007. p. 85-133. ISBN 978-0-12-369415-7. TERAPIA CELULAR; DOENCAS PERIFERICAS; APLICACOES RECONSTRUTIVAS; PREPARACOES DE ILHOTAS; ILHEUS HUMANOS; ILHOTAS DE RATOS; ILHOTAS SUINA; DTZ; ANALISE MORFOLOGICA; ANALISE DE MICROSCOPIA ELETRONICA; ANALISE DE MICROSCOPIA DE LUZ; CITOMETRIA DE FLUXO GRANDE DE PARTICULAS; MEDICOES DE HEMATOCRITO; ULTRA-SONOGRAFIA DOPPLER; NUCLEOS DE CONTAGEM; CONTEUDO DE DNA; ESTIMATIVA DE EQUIVALENTES DO PANCREAS; INTEGRIDADE DA MEMBRANA CELULAR; APOPTOSE; FUNCAO MITOCONDRIAL; FOSFORILACAO OXIDATIVA; POTENCIAL DE MEMBRANA MITOCONDRIAL |
| 219/318 | US=111 / Câncer Delia D, Buscemi G. Regulation of the cell cycle, cell cycle checkpoints, and cancer. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 36-46. ISBN 978-0-470-01852-1. REGULACAO DO CICLO CELULAR; CHECKPOINTS DO CICLO CELULAR; CANCER; DANOS AO DNA; APOPTOSE; SOBREVIVENCIA; RESPOSTAS TRANSCRICIONAIS; VIA DDR; ATM; ESTRESSE OXIDATIVO; MUTACOES SOMATICAS |
| 220/318 | US=111 / Câncer Willimson KE, El Din OS, O'Kane HF. Apoptosis. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 47-59. ISBN 978-0-470-01852-1. APOPTOSE; EQUILIBRIO SOBREVIVENCIA; CONTROLE GENETICO DA APOPTOSE; VIAS APOPTOTICAS; VIA DO RECEPTOR DE MORTE; RECEPTORES DE MORTE; FAMILIA BCL-2; PERMEABILIDADE MITOCONDRIAL; CASPASE; INIBIDOR DE PROTEINAS DE APOPTOSE; PROTEINAS ANTI-APOPTOTICAS; AVALIACAO DA APOPTOSE |